Literature DB >> 16310005

Total knee arthroplasty in hemophilic arthropathy of the knee.

Dae Kyung Bae1, Kyoung Ho Yoon, Hee Sun Kim, Sang Jun Song.   

Abstract

Twenty-five total knee arthroplasties were performed in 21 patients with hemophilia. The mean patient age was 35.8 years and mean follow-up time was 6.2 years. The average preoperative knee score increased from 18.6 points (range, 3-29) to 82.8 points (range, 44-99). The average preoperative knee function score increased from 41.4 points (range, 20-60 points) to 75.8 points (range, 45-95 points). The average preoperative range of motion was 73.4 degrees with an average flexion contracture of 22.6 degrees, whereas the average postoperative range of motion increased to 92.2 degrees with an average flexion contracture of 5.6 degrees. Median consumption of coagulation factor concentrate decreased from 4837 U/month before operation to 1500 U/month 1 year after surgery. The total knee arthroplasty is a useful treatment in severe hemophilic arthropathy to obtain pain relief and functional improvement, and to reduce the need for ongoing treatment using coagulation factor concentrate.

Entities:  

Mesh:

Year:  2005        PMID: 16310005     DOI: 10.1016/j.arth.2005.01.008

Source DB:  PubMed          Journal:  J Arthroplasty        ISSN: 0883-5403            Impact factor:   4.757


  9 in total

1.  Surgical synovectomy of the knee in young haemophiliacs: long-term results of a monocentric series of 23 patients.

Authors:  Virginie Rampal; T Odent; M F Torchet; C Rothschild; C Elie; C Glorion; J P Padovani
Journal:  J Child Orthop       Date:  2010-01-08       Impact factor: 1.548

2.  Haemophilic knee arthropathy: long-term outcome after total knee replacement.

Authors:  Patrick O Zingg; Sandro F Fucentese; Willy Lutz; Brigit Brand; Nadja Mamisch; Peter P Koch
Journal:  Knee Surg Sports Traumatol Arthrosc       Date:  2012-12       Impact factor: 4.342

3.  Long-term results of total knee arthroplasty in haemophilic patients: an 18-year follow-up.

Authors:  Lukas Ernstbrunner; Andreas Hingsammer; Sabrina Catanzaro; Reto Sutter; Brigit Brand; Karl Wieser; Sandro F Fucentese
Journal:  Knee Surg Sports Traumatol Arthrosc       Date:  2016-11-03       Impact factor: 4.342

4.  Total knee arthroplasty in hemophiliacs: gains in range of motion realized beyond twelve months postoperatively.

Authors:  Atul F Kamath; John G Horneff; Angela Forsyth; Valdet Nikci; Charles L Nelson
Journal:  Clin Orthop Surg       Date:  2012-05-17

5.  Perioperative management of hemophilia patients receiving total hip and knee arthroplasty: a complication report of two cases.

Authors:  Toshiyuki Tateiwa; Yasuhito Takahashi; Tsunehito Ishida; Kosuke Kubo; Toshinori Masaoka; Takaaki Shishido; Keiji Sano; Kengo Yamamoto
Journal:  Ther Clin Risk Manag       Date:  2015-09-15       Impact factor: 2.423

Review 6.  Open repair of intraoperative popliteal artery injury during total knee arthroplasty in a patient with severe hemophilia A: A case report and literature review.

Authors:  Bin Feng; Ke Xiao; Jiang Shao; Yu Fan; Xisheng Weng
Journal:  Medicine (Baltimore)       Date:  2017-11       Impact factor: 1.889

7.  Range of motion after total knee arthroplasty in hemophilic arthropathy.

Authors:  Radovan Kubeš; Peter Salaj; Rastislav Hromádka; Josef Včelák; Aleš Antonín Kuběna; Monika Frydrychová; Štěpán Magerský; Michal Burian; Martin Ošťádal; Jan Vaculik
Journal:  BMC Musculoskelet Disord       Date:  2018-05-22       Impact factor: 2.362

8.  How much preoperative flexion contracture is a predictor for residual flexion contracture after total knee arthroplasty in hemophilic arthropathy and rheumatoid arthritis?

Authors:  Hyun Woo Lee; Cheol Hee Park; Dae Kyung Bae; Sang Jun Song
Journal:  Knee Surg Relat Res       Date:  2022-04-08

9.  Simultaneous bilateral total knee arthroplasty in patients with end-stage hemophilic arthropathy: a mean follow-up of 6 years.

Authors:  Chao Jiang; Yan Zhao; Bin Feng; Jiliang Zhai; Yanyan Bian; Guixing Qiu; Xisheng Weng
Journal:  Sci Rep       Date:  2018-01-25       Impact factor: 4.379

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.